Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option
@article{CCO147193,
author = {Dana Narvaez and Gerneiva T. Parkinson and Stephanie L. Graff},
title = {Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option},
journal = {Chinese Clinical Oncology},
volume = {14},
number = {6},
year = {2025},
keywords = {},
abstract = {},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/147193}
}